AMBQ vs RDVT
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
AMBQ exhibits severe financial distress signals, with a Piotroski F-Score of 1/9 indicating extreme operational weakness and no Altman Z-Score available, raising unquantified bankruptcy risk. Despite a strong gross margin of 44.26%, the company reports deep losses across all profitability metrics, including a -50.28% net profit margin and negative ROE/ROA. Insider selling of $0.55M in the last 6 months, coupled with a 34.2% decline over the past year, underscores deteriorating sentiment. While earnings surprises have been positive in recent quarters, they stem from shrinking losses rather than real profitability, and revenue growth is negligible at just 2% YoY. The stock trades at a premium valuation (Price/Sales: 7.33) despite negative earnings and no intrinsic value support.
RDVT presents a dichotomy between exceptional balance sheet health and concerning internal sentiment. While the Piotroski F-Score of 4/9 indicates stability and the company maintains a near-zero debt profile with massive liquidity, the stock is trading at a significant premium to its Graham Number ($12.08) and Intrinsic Value ($26.85). Explosive YoY earnings growth is offset by a bearish technical trend and a highly alarming pattern of C-suite insider selling. Consequently, the strong analyst 'buy' ratings are currently contradicted by the actions of the company's own executives.
Compare Another Pair
Related Comparisons
AMBQ vs RDVT: Head-to-Head Comparison
This page compares Ambiq Micro, Inc. (AMBQ) and Red Violet, Inc. (RDVT) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.